Cargando…
Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis
BACKGROUND AND AIMS: The potassium channel Kv1.3 is a potentially attractive therapeutic target in T cell-mediated inflammatory diseases, as the activity of antigen-activated T cells is selectively impeded by Kv1.3 inhibition. In this study, we examined Kv1.3 as a potential therapeutic intervention...
Autores principales: | Unterweger, Anna-Lena, Jensen, Morten Ø, Giordanetto, Fabrizio, Jogini, Vishwanath, Rüschher, Alena, Seuß, Marietta, Winkelmann, Paula, Koletzko, Leandra, Shaw, David E, Siebeck, Matthias, Gropp, Roswitha, Beigel, Florian, Aszodi, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575044/ https://www.ncbi.nlm.nih.gov/pubmed/33891001 http://dx.doi.org/10.1093/ecco-jcc/jjab078 |
Ejemplares similares
-
NOD/scid IL‐2Rγ(null) mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
por: Unterweger, Anna‐Lena, et al.
Publicado: (2021) -
The PI3K pathway as a therapeutic intervention point in inflammatory bowel disease
por: Winkelmann, Paula, et al.
Publicado: (2021) -
CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
por: Al-amodi, Omar, et al.
Publicado: (2018) -
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
por: Jodeleit, Henrika, et al.
Publicado: (2018) -
Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγ(null) mice reconstituted with human peripheral blood mononuclear cells
por: Jodeleit, Henrika, et al.
Publicado: (2021)